PAVmed (PAVM) Return on Equity (2021 - 2025)
PAVmed (PAVM) has 5 years of Return on Equity data on record, last reported at 0.05% in Q3 2025.
- For Q3 2025, Return on Equity changed N/A year-over-year to 0.05%; the TTM value through Sep 2025 reached 0.05%, changed N/A, while the annual FY2024 figure was 2.14%, 1426.0% down from the prior year.
- Return on Equity reached 0.05% in Q3 2025 per PAVM's latest filing, down from 0.22% in the prior quarter.
- Across five years, Return on Equity topped out at 10.72% in Q3 2024 and bottomed at 18.97% in Q2 2023.
- Average Return on Equity over 5 years is 1.07%, with a median of 0.43% recorded in 2022.
- Peak YoY movement for Return on Equity: plummeted -1742bps in 2023, then surged 2267bps in 2024.
- A 5-year view of Return on Equity shows it stood at 0.98% in 2021, then plummeted by -434bps to 5.23% in 2022, then skyrocketed by 176bps to 3.98% in 2023, then crashed by -344bps to 9.69% in 2024, then skyrocketed by 100bps to 0.05% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Equity were 0.05% in Q3 2025, 0.22% in Q2 2025, and 0.27% in Q1 2025.